Published in Gut on November 01, 1993
Somatostatin in gastroenterology. BMJ (1994) 1.18
Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis. Dig Dis Sci (1998) 0.82
Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci (2005) 0.79
Somatostatin. N Engl J Med (1983) 2.68
Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology (1990) 2.02
Sample size nomograms for interpreting negative clinical studies. Ann Intern Med (1983) 1.81
Somatostatin suppresses secretin and pancreatic exocrine secretion. Science (1975) 1.45
Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg (1989) 1.30
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26
Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology (1968) 1.24
Cytoprotection - organoprotection by somatostatin: gastric and hepatic lesions. Experientia (1982) 1.21
Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography. Gut (1976) 1.17
Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut (1989) 1.15
Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14
Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg (1985) 1.09
Use of somatostatin analog in management of carcinoid syndrome. Dig Dis Sci (1989) 1.08
The use of somatostatin in acute pancreatitis--results of a multicenter trial. Hepatogastroenterology (1990) 1.07
Glucagon therapy in acute pancreatitis. Report of a double-blind trial. Gut (1978) 1.06
Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg (1991) 1.05
Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg (1988) 1.03
Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas (1986) 1.02
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut (1992) 1.02
Nasogastric suction in the treatment of alcoholic pancreatitis. A controlled study. JAMA (1974) 0.98
Treatment of pancreatic pseudocysts with octreotide. Lancet (1991) 0.96
Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study. Gastroenterology (1979) 0.95
Relationship between the functional status of the reticuloendothelial system and the outcome of experimentally induced pancreatitis in young mice. Gastroenterology (1983) 0.94
Somatostatin therapy of acute experimental pancreatitis. Gut (1977) 0.93
Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut (1991) 0.92
A clinical trial of cimetidine in acute pancreatitis. Surg Gynecol Obstet (1982) 0.90
The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest Endosc (1991) 0.89
A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. Surg Gynecol Obstet (1992) 0.88
Effect of somatostatin 14 on pure human pancreatic secretion. Dig Dis Sci (1987) 0.88
Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc (1991) 0.88
Protective effect of glucan-enhanced macrophage function in experimental pancreatitis. Am J Surg (1987) 0.87
Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med (1987) 0.87
Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res (1988) 0.86
Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res (1979) 0.84
A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas (1991) 0.84
Treatment of acute pancreatitis with somatostatin: a multicenter double blind study. N Engl J Med (1980) 0.84
Is nasogastric suction necessary in acute pancreatitis? Br Med J (1978) 0.84
Effects of a somatostatin analogue (SMS 201-995) on hepatic and splenic reticulo-endothelial function in the rat. Br J Surg (1985) 0.82
Vasoactive drugs in acute pancreatitis. Arch Surg (1984) 0.82
Effects of somatostatin on acute canine experimental pancreatitis. Int J Pancreatol (1987) 0.81
A microsphere study on the effects of somatostatin and secretin on regional blood flow in anesthetized dogs. Regul Pept (1982) 0.80
The effects of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxaemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin Wochenschr (1986) 0.80
[Effect of somatostatin on amylase level and pancreatitis rate following ERCP]. Med Welt (1984) 0.79
Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop. Int J Pancreatol (1988) 0.79
Cytoprotective properties of somatostatins. Klin Wochenschr (1986) 0.78
Microcirculatory effects of somatostatin in acute pancreatitis. Eur Surg Res (1988) 0.78
Effect of SMS201-995 (a long-acting somatostatin analog) on bile-induced acute hemorrhagic pancreatitis in the dog. Am Surg (1989) 0.78
Somatostatin stimulates clearance and hepatic uptake of colloidal carbon in the rat. Life Sci (1983) 0.78
Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin. Metabolism (1990) 0.78
Treatment of experimentally induced pancreatitis in ex vivo perfused canine pancreas with the somatostatin analogue octreotide. Curr Surg (1991) 0.77
[Use of somatostatin in the therapy of acute pancreatitis. Controlled clinical study]. Minerva Chir (1985) 0.77
Effect of somatostatin on rat exocrine pancreatic secretory process in normal and diseased state. Z Gastroenterol (1980) 0.76
[Role of somatostatin and parenteral nutrition in the treatment of acute pancreatitis. Personal experience]. Minerva Chir (1989) 0.76
[Use of somatostatin in acute pancreatitis of biliary origin]. Minerva Med (1987) 0.76
Is duodenitis a dyspeptic myth? Lancet (1977) 6.17
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet (1994) 3.29
Prognostic factors in acute pancreatitis. Gut (1984) 2.94
High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg (1999) 2.78
Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg (2002) 2.72
A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol (2005) 2.63
A prospective study of acute pancreatitis. Br J Surg (1975) 2.45
Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg (1990) 2.36
Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg (1981) 2.29
C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg (1989) 2.11
Hypocalcaemia of acute pancreatitis: the effect of hypoalbuminaemia. Curr Med Res Opin (1976) 2.06
Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol (1999) 2.03
Observations on acute pancreatitis. Br J Surg (1974) 2.00
Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med (1985) 1.97
Bile duct injury and bile leakage in laparoscopic cholecystectomy. Br J Surg (1995) 1.87
Value of splenic preservation during distal pancreatectomy for chronic pancreatitis. Br J Surg (1999) 1.81
Pancreatic necrosis: assessment of outcome related to quality of life and cost of management. Br J Surg (1993) 1.77
Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg (2000) 1.75
Letter: Glucagon therapy in acute pancreatitis. Br Med J (1974) 1.74
Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg (1997) 1.73
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
Preventing complications of laparoscopy. Br J Surg (1993) 1.70
A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) (1985) 1.62
Is an early ultrasound scan of value in acute pancreatitis? Br J Surg (1982) 1.61
Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man. Br J Surg (1985) 1.54
Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats. Br J Surg (1990) 1.52
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Changing patterns of incidence and mortality from acute pancreatitis in Scotland, 1961-1985. Br J Surg (1990) 1.50
Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet (1990) 1.49
Randomized trial of different insufflation pressures for laparoscopic cholecystectomy. Br J Surg (1997) 1.47
Changes in the hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg (1989) 1.45
Symptomatic outcome 1 year after laparoscopic and minilaparotomy cholecystectomy: a randomized trial. Br J Surg (1995) 1.44
Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br J Surg (2002) 1.40
Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis (2011) 1.40
Somatostatin and variceal haemorrhage. Lancet (1984) 1.40
Laparoscopic and minilaparotomy cholecystectomy: a randomized trial comparing postoperative pain and pulmonary function. Surgery (1994) 1.38
Proceedings: A prospective survey of the treatment of acute pancreatitis. Gut (1974) 1.38
Excision of bullae without pleurectomy in patients with spontaneous pneumothorax. Br J Surg (1981) 1.37
Hyperlipidaemia, alcohol abuse and acute pancreatitis. Br J Surg (1984) 1.35
Acute superior mesenteric ischaemia. Br J Surg (1987) 1.35
Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet (1985) 1.34
Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev (2007) 1.30
Fatal acute pancreatitis. Gut (1988) 1.29
Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol (2001) 1.28
Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg (1996) 1.28
The continuing challenge of early mortality in acute pancreatitis. Br J Surg (2004) 1.26
Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage. BMJ (1997) 1.23
Acute pancreatitis associated with tumour metastases in the pancreas. Digestion (1981) 1.22
Early outcome after open versus extraperitoneal endoscopic tension-free hernioplasty: a randomized clinical trial. Surgery (1996) 1.21
The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis (2003) 1.20
Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int J Pancreatol (2000) 1.17
Nutritional deficiencies after bariatric surgery. Obes Surg (2007) 1.16
Gastric emptying in patients with constipation following childbirth and due to idiopathic slow transit. Br J Surg (1997) 1.15
A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol (1992) 1.15
The early identification of patients with gallstone associated pancreatitis using clinical and biochemical factors only. Ann Surg (1983) 1.13
What effect does the duration of an inguinal hernia have on patient symptoms? J Am Coll Surg (2001) 1.12
Parathyroid hormone and calcium homeostasis in acute pancreatitis. Br J Surg (1978) 1.11
Pancreatitis, pregnancy and gallstones. Br J Obstet Gynaecol (1980) 1.11
Needlestick injury in surgeons: what is the incidence? J R Coll Surg Edinb (1991) 1.10
Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg (1985) 1.09
A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol (1985) 1.09
Secondary acute pancreatitis: aetiology, prevention, diagnosis and management. Br J Surg (1978) 1.09
A phase II trial of marimastat in advanced pancreatic cancer. Br J Cancer (2001) 1.08
Parathyroid carcinoma. Br J Surg (2005) 1.07
Arterial hypoxia in acute pancreatitis. Br J Surg (1977) 1.05
Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut (1977) 1.03
Epidemiology of sharps accidents in general surgery. J R Coll Surg Edinb (1991) 1.03
Amylase and gut infarction. Br J Surg (1986) 1.01
Relationship between gastric emptying of solids and gall bladder emptying in normal subjects. Gut (1985) 1.00
Surgical treatment of acute necrotizing pancreatitis. Br J Surg (1988) 1.00
Patients with ampullary carcinoma are prone to other malignant tumours. Br J Cancer (1988) 0.99
Laparoscopic fundoplication: learning curve and patient satisfaction. Ann R Coll Surg Engl (2003) 0.99
A prospective study of the clinical value and accuracy of grey scale ultrasound in detecting gallstones. Br J Surg (1978) 0.99
Deaths from acute pancreatitis: why do we miss the diagnosis so frequently? Int J Pancreatol (1988) 0.98
Acute pancreatitis and renal cortical necrosis. Nephrol Dial Transplant (1990) 0.98
Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae. Eur J Gastroenterol Hepatol (1995) 0.98
The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis (2008) 0.98
Management of periampullary carcinoma. Br J Surg (1987) 0.95
Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer (2003) 0.94
Relationship between gastric emptying of liquid and postvagotomy diarrhoea. Br J Surg (1988) 0.94
A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. ISRN Gastroenterol (2010) 0.93
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut (2003) 0.93
Detection of p53 mutations in precancerous gastric tissue. Br J Cancer (2003) 0.92
The incidence and prognosis of body wall ecchymosis in acute pancreatitis. Surg Gynecol Obstet (1984) 0.92
Hepatobiliary complications in chronic pancreatitis. Gut (1989) 0.91
Small bowel resistances and the gastroduodenal brake. Gut (1987) 0.90
Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute pancreatitis. Br J Surg (2000) 0.90
Survival of surgical patients with carcinoma, lymphoma and carcinoid tumours of the small bowel. Br J Surg (1986) 0.90
The mechanism of arterial hypoxia occurring in acute pancreatitis. Q J Med (1980) 0.89
Ventilatory and blood gas changes during laparoscopic and open cholecystectomy. Br J Surg (1993) 0.88
Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells. Carcinogenesis (2012) 0.88
Macroamylasaemia: a report of two cases. Scott Med J (1973) 0.88
Gall bladder emptying in normal subjects--a data base for clinical cholescintigraphy. Gut (1987) 0.88
Acute pancreatitis: a prospective study on some factors in mortality. Bull Soc Int Chir (1975) 0.87